Global DNA & Gene Chip (Microarray) Market (2010 - 2015)

Date: May 22, 2011
Pages: 331
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GDD6E184D7CEN
Leaflet:

Download PDF Leaflet

Global DNA & Gene Chip (Microarray) Market (2010 - 2015)
Report Description:

Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.

Gene Expression currently forms the largest application market as gene expression products are used in a wide variety of research activities including life sciences research, clinical diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis and treatment application is expected to dominate the applications market by 2015; accounting for about 24% share in the market.

Scope of the report

This research report categorizes the Global DNA & Gene Chip (microarray) market on the basis of applications, types, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

On the basis of applications

Gene Expression, Cancer Diagnostics & Treatments, Drug Discovery, Genetics (DNA sequencing by hybridization, reverse genetics, functional genomics and genomic mismatch scanning, gene mapping, diagnosis), SNP Analysis, Screening & Monitoring of patient data during clinical trials, Proteomics, Toxicogenomics, Microbial Genotyping, Agricultural Biology, and Environmental Control

On the basis of types

Oligonucleotide DNA Microarrays (oDNA) and Complementary DNA Microarrays (cDNA)

On the basis of geography

North America, Europe, Asia, and Rest of the World.

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments. In addition, the report also provides more than 30 company profiles covering all the sub-segments.

What makes our reports unique?
  • We provide the longest market segmentation chain in this industry.
  • We provide 10% customization. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
  • We conduct detailed market positioning, product positioning, and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
  • Comprehensive market analysis for the following sectors:
    Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered
  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishing and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
EXECUTIVE SUMMARY

OBJECTIVE
MARKET SCENARIO

1 INTRODUCTION

1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY

2 SUMMARY

3 MARKET OVERVIEW

3.1 INTRODUCTION
3.2 DNA MICROARRAY REQUIREMENTS
  3.2.1 FIRM TETHERING
  3.2.2 UNHINDERED BINDING
  3.2.3 USING LARGER & DNA MOLECULES
  3.2.4 NO CROSS CONTAMINATION
3.3 DNA MICROARRAY DEVELOPMENT TRENDS
  3.3.1 GLASS ARRAYS TRENDS
  3.3.2 AMERSHAM'S COATING TECHNOLOGY
  3.3.3 AGILENT TECHNOLOGY
  3.3.4 PROBE TECHNOLOGY
3.4 COMPARISON OF INKJET & PHOTOLITHOGRAPHIC TECHNOLOGY
  3.4.1 PHOTOLITHOGRAPHY
  3.4.2 INKJET TECHNOLOGY
3.5 KEY CHALLENGES IN DNA/GENE MICROARRAY MANUFACTURING
  3.5.1 BASE PAIR MISMATCH
  3.5.2 POOR BINDING
  3.5.3 HYBRIDIZATION
  3.5.4 VARIABLE SIGNAL STRENGTHS
  3.5.5 INTERPRETATION OF MICROARRAYS
  3.5.6 INTRAMICROARRAY VARIABILITY & INTERMICROARRAY VARIABILITY
  3.5.7 THE INCOMPLETE REACTION PROBLEM
  3.5.8 PROBE DESIGN
  3.5.9 SUBSTRATES
  3.5.10 MARKER MOLECULES
  3.5.11 UNREACTIVE SURFACE
3.6 MARKET DRIVERS
  3.6.1 LARGE SCALE DNA/GENE CHIP INITIATIVES
  3.6.2 GROWTH OF PERSONALIZED MEDICINE
  3.6.3 NEED FOR EARLY CANCER DETECTION & CANCER DIAGNOSIS
  3.6.4 DNA/GENE CHIPS MINIATURIZATION
  3.6.5 GOVERNMENT FUNDING BOOSTS MARKET GROWTH
3.7 RESTRAINTS
  3.7.1 KNOWLEDGE CONSTRAINTS WITH RESPECT TO TECHNICAL KNOW-HOW & SKILLED EMPLOYEES
  3.7.2 ALTERNATE TECHNOLOGIES
3.8 OPPORTUNITIES
  3.8.1 ECONOMIES OF ASIA PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO THE DNA MICROARRAY MARKET
3.9 BURNING ISSUES
  3.9.1 PATENT DISPUTES
3.10 MARKET TRENDS
  3.10.1 RELOCATING MANUFACTURING FACILITIES TO GAIN COMPETITIVE EDGE
    3.10.1.1 Advantage Singapore
  3.10.2 WINNING IMPERATIVES
    3.10.2.1 Standardization
    3.10.2.2 Size
    3.10.2.3 Cost
    3.10.2.4 Compatibility
    3.10.2.5 End-to-end solutions
3.11 PATENT ANALYSIS
3.12 END-USER ANALYSIS
3.13 MARKET SHARE FOR MAJOR PLAYERS

4 DNA/GENE CHIPS (DNA MICROARRAY) MARKET BY TYPES & APPLICATIONS

4.1 INTRODUCTION
4.2 MARKET SEGMENTATION
4.3 DNA/GENE CHIPS (DNA MICROARRAY) MARKET BY TYPES
  4.3.1 OLIGONUCLEOTIDE BASED CHIPS
    4.3.1.1 Photolithographic (light generated) oligonucleotide chips
    4.3.1.2 Inkjet print technology generated oligonucleotide chips
  4.3.2 CDNA CHIPS
    4.3.2.1 Mechanical microspotting generated cDNA chips
    4.3.2.2 Inkjet print technology generated cDNA chips
4.4 DNA/GENE CHIPS (DNA MICROARRAY) MARKET BY APPLICATIONS
  4.4.1 GENE EXPRESSION
  4.4.2 SNP ANALYSIS
  4.4.3 CANCER DIAGNOSIS & TREATMENT
  4.4.4 GENOMICS
    4.4.4.1 DNA sequencing in hybridization
    4.4.4.2 Functional genomics & genomic mis-match scanning
    4.4.4.3 Reverse genetics
    4.4.4.4 Diagnosis & genetic mapping
  4.4.5 PROTEOMICS
  4.4.6 AGRICULTURAL BIOLOGY
  4.4.7 ENVIRONMENTAL CONTROL
  4.4.8 TOXICOGENOMICS
  4.4.9 DRUG DISCOVERY
  4.4.10 SCREENING & MONITORING OF PATIENT DATA IN CLINICAL TRIALS
  4.4.11 MICROBIAL GENOTYPING

5 GEOGRAPHIC ANALYSIS

5.1 INTRODUCTION
5.2 NORTH AMERICA
  5.2.1 U.S.
  5.2.2 CANADA
5.3 EUROPE
  5.3.1 GERMANY
  5.3.2 FRANCE
  5.3.3 ITALY
  5.3.4 SPAIN
  5.3.5 UNITED KINGDOM
5.4 ASIA
  5.4.1 INDIA
  5.4.2 CHINA
  5.4.3 JAPAN
  5.4.4 SOUTH KOREA
5.5 REST OF THE WORLD (ROW)

6 COMPETITIVE ANALYSIS

6.1 KEY STRATEGIES

7 COMPANY PROFILES

7.1 AFFYMETRIX INC
  7.1.1 OVERVIEW
  7.1.2 FINANCIALS
  7.1.3 PRODUCTS & SERVICES
  7.1.4 STRATEGY
  7.1.5 DEVELOPMENTS
7.2 AGILENT TECHNOLOGIES INC
  7.2.1 OVERVIEW
  7.2.2 FINANCIALS
  7.2.3 PRODUCTS & SERVICES
  7.2.4 STRATEGY
  7.2.5 DEVELOPMENTS
7.3 BIOMЙRIEUX SA
  7.3.1 OVERVIEW
  7.3.2 FINANCIALS
  7.3.3 PRODUCTS & SERVICES
  7.3.4 STRATEGY
  7.3.5 DEVELOPMENTS
7.4 BIOMETRIX TECHNOLOGY INC
  7.4.1 OVERVIEW
  7.4.2 PRODUCTS & SERVICES
  7.4.3 STRATEGY
7.5 BIONEER CORP
  7.5.1 OVERVIEW
  7.5.2 FINANCIALS
  7.5.3 PRODUCTS & SERVICES
  7.5.4 STRATEGY
  7.5.5 DEVELOPMENTS
7.6 CAPITALBIO CORP
  7.6.1 OVERVIEW
  7.6.2 PRODUCTS & SERVICES
  7.6.3 STRATEGY
  7.6.4 DEVELOPMENTS
7.7 EUROFINS MWG OPERON
  7.7.1 OVERVIEW
  7.7.2 PRODUCTS & SERVICES
  7.7.3 STRATEGY
  7.7.4 DEVELOPMENTS
7.8 GREINER BIO-ONE
  7.8.1 OVERVIEW
  7.8.2 PRODUCT & SERVICES
  7.8.3 STRATEGY
  7.8.4 DEVELOPMENTS
7.9 ILLUMINA INC
  7.9.1 OVERVIEW
  7.9.2 FINANCIALS
  7.9.3 PRODUCTS & SERVICES
  7.9.4 STRATEGY
  7.9.5 DEVELOPMENTS
7.10 LC SCIENCES
  7.10.1 OVERVIEW
  7.10.2 PRODUCTS & SERVICES
  7.10.3 STRATEGY
  7.10.4 DEVELOPMENTS
7.11 LIFEGEN TECHNOLOGIES
  7.11.1 OVERVIEW
  7.11.2 PRODUCTS & SERVICES
  7.11.3 STRATEGY
  7.11.4 DEVELOPMENTS
7.12 LIFE TECHNOLOGIES CORP
  7.12.1 OVERVIEW
  7.12.2 FINANCIALS
  7.12.3 PRODUCTS & SERVICES
  7.12.4 STRATEGY
  7.12.5 DEVELOPMENTS
7.13 MACROGEN INC
  7.13.1 OVERVIEW
  7.13.2 PRODUCTS & SERVICES
  7.13.3 STRATEGY
  7.13.4 DEVELOPMENTS
7.14 MICROARRAYS INC
  7.14.1 OVERVIEW
  7.14.2 PRODUCTS & SERVICES
  7.14.3 STRATEGY
  7.14.4 DEVELOPMENTS
7.15 NGK INSULATORS LTD
  7.15.1 OVERVIEW
  7.15.2 FINANCIALS
  7.15.3 PRODUCTS & SERVICES
  7.15.4 STRATEGY
  7.15.5 DEVELOPMENTS
7.16 OCIMUM BIOSOLUTIONS LTD
  7.16.1 OVERVIEW
  7.16.2 PRODUCTS & SERVICES
  7.16.3 STRATEGY
  7.16.4 DEVELOPMENTS
7.17 OXFORD GENE TECHNOLOGY
  7.17.1 OVERVIEW
  7.17.2 PRODUCTS & SERVICES
  7.17.3 STRATEGY
  7.17.4 DEVELOPMENTS
7.18 PERKINELMER
  7.18.1 OVERVIEW
  7.18.2 FINANCIALS
  7.18.3 PRODUCTS & SERVICES
  7.18.4 STRATEGY
  7.18.5 DEVELOPMENTS
7.19 PAMGENE INTERNATIONAL B.V.
  7.19.1 OVERVIEW
  7.19.2 PRODUCT & SERVICES
  7.19.3 STRATEGY
7.20 ROCHE NIMBLEGEN INC
  7.20.1 OVERVIEW
  7.20.2 PRODUCTS & SERVICES
  7.20.3 STRATEGY
  7.20.4 DEVELOPMENTS
7.21 SAVYON DIAGNOSTICS LTD
  7.21.1 OVERVIEW
  7.21.2 PRODUCTS & SERVICES
  7.21.3 STRATEGY
  7.21.4 DEVELOPMENTS
7.22 SEQUENOM INC
  7.22.1 OVERVIEW
  7.22.2 FINANCIALS
  7.22.3 PRODUCTS & SERVICES
  7.22.4 STRATEGY
  7.22.5 DEVELOPMENTS
7.23 SHANGHAI BIOCHIP CO LTD
  7.23.1 OVERVIEW
  7.23.2 PRODUCTS & SERVICES
  7.23.3 STRATEGY
  7.23.4 DEVELOPMENTS
7.24 SIGMA-ALDRICH
  7.24.1 OVERVIEW
  7.24.2 FINANCIALS
  7.24.3 PRODUCTS & SERVICES
  7.24.4 STRATEGY
  7.24.5 DEVELOPMENTS
7.25 SURMODICS INC
  7.25.1 OVERVIEW
  7.25.2 FINANCIALS
  7.25.3 PRODUCT & SERVICES
  7.25.4 STRATEGY
  7.25.5 DEVELOPMENTS
7.26 SCIENION AG
  7.26.1 OVERVIEW
  7.26.2 PRODUCTS & SERVICES
  7.26.3 STRATEGY
  7.26.4 DEVELOPMENTS
7.27 TOSHIBA CORP
  7.27.1 OVERVIEW
  7.27.2 FINANCIALS
  7.27.3 PRODUCTS & SERVICES
7.28 WAFERGEN BIOSYSTEMS INC
  7.28.1 OVERVIEW
  7.28.2 FINANCIALS
  7.28.3 PRODUCTS & SERVICES
  7.28.4 STRATEGY
  7.28.5 DEVELOPMENTS
7.29 ARRAYIT CORP
  7.29.1 OVERVIEW
  7.29.2 FINANCIALS
  7.29.3 PRODUCTS & SERVICES
  7.29.4 STRATEGY
  7.29.5 DEVELOPMENTS
7.30 OTHERS
  7.30.1 APPLIED MICROARRAYS INC
    7.30.1.1 Overview
    7.30.1.2 Products & Services
  7.30.2 CANON INC
    7.30.2.1 Overview
    7.30.2.2 Financials
    7.30.2.3 Products & Services
  7.30.3 GENISPHERE LLC
    7.30.3.1 Overview
    7.30.3.2 Products & Services
  7.30.4 HITACHI LTD
    7.30.4.1 Overview
    7.30.4.2 Financials
    7.30.4.3 Products & Services
  7.30.5 CYTOPATHFINDER INC
    7.30.5.1 Overview
    7.30.5.2 Products & Services
  7.30.6 INTEGRATED DNA TECHNOLOGIES
    7.30.6.1 Overview
    7.30.6.2 Products & Services
  7.30.7 EXIQON
    7.30.7.1 Overview
    7.30.7.2 Financials
    7.30.7.3 Products & Services
  7.30.8 SAMSUNG ELECTRONICS CO LTD
    7.30.8.1 Overview
    7.30.8.2 Financials
    7.30.8.3 Products & Services
  7.30.9 PROMEGA CORP
    7.30.9.1 Overview
    7.30.9.2 Products & Services
  7.30.10 THERMO FISHER SCIENTIFIC INC
    7.30.10.1 Overview
    7.30.10.2 Financials
    7.30.10.3 Products & Services

APPENDIX

U.S. PATENTS
EUROPE PATENTS
JAPAN PATENTS
WIPO PATENTS

LIST OF TABLES

TABLE 1 GLOBAL DNA & GENE CHIP MARKET REVENUE, BY TYPES, 2008 – 2015 ($MILLION)
TABLE 2 GLOBAL DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 3 TOP 5 DNA MICROARRAY TECHNOLOGIES
TABLE 4 COMPARISON BETWEEN PHOTOLITHOGRAPHY & INKJET TECHNOLOGY
TABLE 5 PATENT DISPUTES IN DNA MICROARRAY MARKET
TABLE 6 TAX ENVIRONMENT
TABLE 7 TAX ENVIRONMENT: FOR NEW START UP COMPANIES IN SINGAPORE
TABLE 8 ODNA CHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 9 ODNA CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 10 CDNA CHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)
TABLE 11 CDNA CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 12 GLOBAL DNA & GENE CHIP MARKET REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)
TABLE 13 GLOBAL DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 14 GENE EXPRESSION PRODUCT PORTFOLIO
TABLE 15 GENE EXPRESSION MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 16 GENE EXPRESSION MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 17 SNP ANALYSIS PRODUCT PORTFOLIO
TABLE 18 SNP ANALYSIS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 19 SNP ANALYSIS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 20 CANCER DIAGNOSTICS & TREATMENT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 21 CANCER DIAGNOSTICS & TREATMENT MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 22 CANCER DIAGNOSIS & TREATMENT PRODUCT PORTFOLIO
TABLE 23 GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 24 GENOMICS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 25 DIAGNOSIS & GENETIC MAPPING PRODUCT PORTFOLIO
TABLE 26 PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 27 PROTEOMICS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 28 AGRICULTURAL BIOLOGY PRODUCT PORTFOLIO
TABLE 29 AGRICULTURAL BIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 30 AGRICULTURAL BIOLOGY MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 31 ENVIRONMENTAL CONTROL MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)
TABLE 32 ENVIRONMENTAL CONTROL MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 33 TOXICOGENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 34 TOXICOGENOMICS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 35 DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 37 SCREENING & MONITORING PATIENT DATA IN CLINICAL TRIALS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 38 SCREENING & MONITORING PATIENT DATA IN CLINICAL TRIALS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 39 MICROBIAL GENOTYPING MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 40 MICROBIAL GENOTYPING MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 41 NORTH AMERICA: DNA & GENE CHIP MARKET, BY REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 42 NORTH AMERICA: DNA & GENE CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 43 NORTH AMERICA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)
TABLE 44 NORTH AMERICA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 45 U.S.: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($MILLION)
TABLE 46 U.S.: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 47 U.S.: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)
TABLE 48 U.S.: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 49 CANADA: DNA & GENE CHIP MARKET , BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 50 CANADA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 51 CANADA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 52 CANADA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 53 EUROPE: DNA & GENE CHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 54 EUROPE: DNA & GENE CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 55 EUROPE: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)
TABLE 56 EUROPE: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 57 GERMANY: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 58 GERMANY: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 59 GERMANY: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 60 GERMANY: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 61 FRANCE: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 62 FRANCE: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 63 FRANCE: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 64 FRANCE: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 65 ITALY: DNA & GENE CHIP MARKET , BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 66 ITALY: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 67 ITALY: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 68 ITALY: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 69 SPAIN: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 70 SPAIN: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 71 SPAIN: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 72 SPAIN: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 73 UK: DNA & GENE CHIP MARKET , BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 74 UK: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 75 UK: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 76 UK: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 77 ASIA: DNA & GENE CHIP MARKET, BY REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 78 ASIA: DNA & GENE CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 79 ASIA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)
TABLE 80 ASIA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 81 INDIA: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 82 INDIA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 83 INDIA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 84 INDIA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 85 CHINA: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 86 CHINA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 87 CHINA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 88 CHINA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 89 JAPAN: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 90 JAPAN: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 91 JAPAN: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 92 JAPAN: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 93 SOUTH KOREA: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 94 SOUTH KOREA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 95 SOUTH KOREA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 96 SOUTH KOREA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 97 ROW: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)
TABLE 98 ROW: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 99 ROW: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 100 ROW: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 101 NEW PRODUCT LAUNCHES
TABLE 102 MERGERS & ACQUISITIONS
TABLE 103 AGREEMENTS & COLLABORATIONS
TABLE 104 PARTNERSHIPS
TABLE 105 APPROVALS
TABLE 106 EXPANSIONS
TABLE 107 AFFYMETRIX INC: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 108 AFFYMETRIX INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 109 AFFYMETRIX INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 110 AGILENT TECHNOLOGIES: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 111 AGILENT TECHNOLOGIES: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 112 AGILENT TECHNOLOGIES: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 113 BIOMЙRIEUX SA: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 114 BIONEER CORP: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 115 BIONEER CORP: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 116 ILLUMINA INC: TOTAL REVENUES & R&D EXPENSE FOR FISCAL YEAR ENDED ($THOUSAND)
TABLE 117 ILLUMINA INC: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)
TABLE 118 ILLUMINA INC: TOTAL REVENUES, BY SEGMENTS ($THOUSAND)
TABLE 119 LIFE TECHNOLOGIES CORP: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 120 LIFE TECHNOLOGIES CORP: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)
TABLE 121 LIFE TECHNOLOGIES CORP: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 122 NGK INSULATORS LTD: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)
TABLE 123 NGK INSULATORS LTD: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 124 NGK INSULATORS LTD: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 125 PERKINELMER: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 126 PERKINELMER: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 127 PERKINELMER: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 128 SEQUENOM INC: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)
TABLE 129 SEQUENOM INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 130 SEQUENOM INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 131 SIGMA-ALDRICH: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 132 SIGMA-ALDRICH: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 133 SURMODICS INC: TOTAL REVENUE ($THOUSAND)
TABLE 134 TOSHIBA CORP: TOTAL REVENUES & R&D EXPENSES ($BILLION)
TABLE 135 TOSHIBA CORP: TOTAL REVENUES, BY GEOGRAPHY ($BILLION)
TABLE 136 TOSHIBA CORP: TOTAL REVENUES, BY SEGMENTS ($BILLION)
TABLE 137 WAFERGEN BIOSYSTEMS: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)
TABLE 138 ARRAYIT CORP: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)
TABLE 139 ARRAYIT CORP: TOTAL REVENUES, BY SEGMENTS ($THOUSAND)
TABLE 140 CANON INC: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 141 CANON INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 142 CANON INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 143 HITACHI LTD: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 144 HITACHI LTD: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 145 HITACHI LTD: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 146 EXIQON: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)
TABLE 147 EXIQON: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)
TABLE 148 EXIQON A/S: TOTAL REVENUES, BY SEGMENTS ($THOUSAND)
TABLE 149 SAMSUNG ELECTRONICS CO LTD: TOTAL REVENUES & R&D EXPENSES $MILLION)
TABLE 150 SAMSUNG ELECTRONICS CO LTD: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 151 SAMSUNG ELECTRONICS CO LTD: TOTAL REVENUES, BY SEGMENTS ($MILLION)
TABLE 152 THERMO FISHER SCIENTIFIC INC: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 153 THERMO FISHER SCIENTIFIC INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 154 THERMO FISHER SCIENTIFIC INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL DNA & GENE CHIP MARKET 2010 ($MILLION)
FIGURE 2 DNA MICROARRAY MILESTONES
FIGURE 3 MICROFLUIDICS CHIP
FIGURE 4 PATENT ANALYSIS BY ASSIGNEE
FIGURE 5 COMPOSITION OF END-USER (2010 & 2015)
FIGURE 6 MARKET SHARE ANALYSIS (2009)
FIGURE 7 DNA MICROARRAY MARKET SEGMENTATION
FIGURE 8 ODNA MICROARRAY
FIGURE 9 CDNA MICROARRAY
FIGURE 10 MAJOR GROWTH STRATEGIES IN DNA & GENE CHIP MARKET (JANUARY 2008 – MARCH 2011)
Skip to top


Ask Your Question

Global DNA & Gene Chip (Microarray) Market (2010 - 2015)
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: